Citeline Podcasts

Citeline Podcasts

【3分で解説世界のファーマ】第22回 AD治療、費用対効果に悩む英国 (Japanese-language podcast)

Oct 29, 2024 · 3m

Listen to Episode

✨ AI Summary

UK faces challenges with Alzheimer's drug cost-effectiveness.
Lilly's Kisunla approved by MHRA but not NICE.
Discussion on the financial burden of new Alzheimer's treatments.

More from Citeline Podcasts

Scrip's Five Must-Know Things - Oct. 13, 2026

Oct 13, 2026 · 16m

Strategic Intent: Celebrity Marketing In The Age Of Promo Crackdown

Oct 13, 2026 · 26m

Drug Fix: US FDA’s Peptide Drama, More Transparency, Ibogaine Clinical Trial Plans

Oct 9, 2026 · 41m

Off-Patent, On Record: Navigating The Financial Strategy Behind Litigation With Sandoz’s Julia Pike

Oct 6, 2026 · 24m

View all episodes →